We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+5.08%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$126M
AUM Growth
-$25.5M
Cap. Flow
-$24.9M
Cap. Flow %
-19.84%
Top 10 Hldgs %
47.53%
Holding
143
New
16
Increased
24
Reduced
11
Closed
74

Sector Composition

Rank Sector Weight
1 Healthcare 52.52%
2 Technology 21.51%
3 Consumer Discretionary 5.99%
4 Communication Services 3.46%
5 Financials 2.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIDU icon
76
Baidu
BIDU
$36.1B
-4,043
Closed -$622K
CECO icon
77
Ceco Environmental
CECO
$4.2B
-13,180
Closed -$93K
CRDF icon
78
Cardiff Oncology
CRDF
$78.6M
-15,501
Closed -$103K
CRIS icon
79
Curis
CRIS
$4.56M
-431
Closed -$1.35M
DAKT icon
80
Daktronics
DAKT
$1.03B
-12,621
Closed -$69K
EGY icon
81
Vaalco Energy
EGY
$628M
-41,614
Closed -$122K
EPIX
82
DELISTED
ESSA Pharma
EPIX
-143,566
Closed -$1.15M
EPM icon
83
Evolution Petroleum
EPM
$134M
-26,066
Closed -$148K
ETON icon
84
Eton Pharmaceutcials
ETON
$1.16B
-21,517
Closed -$109K
EVC icon
85
Entravision Communication
EVC
$812M
-17,751
Closed -$126K
EWTX icon
86
Edgewise Therapeutics
EWTX
$4.84B
-39,133
Closed -$650K
FIVN icon
87
FIVE9
FIVN
$2.48B
-17,400
Closed -$2.78M
GNSS icon
88
Genasys
GNSS
$76.1M
-10,721
Closed -$55K
HOOK
89
DELISTED
HOOKIPA Pharma
HOOK
-1,205
Closed -$71K
HROW icon
90
Harrow
HROW
$1.45B
-14,211
Closed -$129K
IGMS
91
DELISTED
IGM Biosciences
IGMS
-15,446
Closed -$1.02M
III icon
92
Information Services Group
III
$250M
-11,006
Closed -$79K
LINC icon
93
Lincoln Educational Services
LINC
$962M
-12,541
Closed -$84K
LOMA
94
Loma Negra
LOMA
$1.16B
-10,276
Closed -$73K
LXRX icon
95
Lexicon Pharmaceuticals
LXRX
$1.05B
-27,978
Closed -$135K
LYTS icon
96
LSI Industries
LYTS
$913M
-10,800
Closed -$84K
LITS
97
Lite Strategy Inc
LITS
$31.3M
-1,716
Closed -$95K
NAT icon
98
Nordic American Tanker
NAT
$1.3B
-40,323
Closed -$103K
NBIX icon
99
Neurocrine Biosciences
NBIX
$16.5B
-13,205
Closed -$1.27M
NVAX icon
100
Novavax
NVAX
$1.28B
-4,978
Closed -$1.03M

Similar funds

HighVista Strategies's Q4 2021 Portfolio in Review

As of Q4 2021, HighVista Strategies held 143 positions worth $126M, down 17% from $151M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

HighVista Strategies withdrew a net $24.9M in Q4 2021, closing 74 positions and reducing 11 holdings. Its most notable exit was PPD, Inc. Common Stock, an estimated $3.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 44% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, HighVista Strategies opened a new position in Coherent Inc worth $3.63M.

  • HighVista Strategies's largest Q4 2021 buy was Coherent Inc: 13,600 shares worth $3.63M.
  • HighVista Strategies added most to Gritstone bio, Inc. Common Stock in Q4 2021, an estimated $1.1M increase.
  • HighVista Strategies's biggest Q4 2021 reduction was Dell, cutting an estimated $19.3M.
  • HighVista Strategies fully exited PPD, Inc. Common Stock in Q4 2021, selling an estimated $3.5M.
  • HighVista Strategies's ten largest holdings make up 48% of its $126M portfolio in Q4 2021.
  • HighVista Strategies opened 16 new positions and closed 74 in Q4 2021.
  • HighVista Strategies's portfolio value fell 17% quarter-over-quarter to $126M.

Based on HighVista Strategies's 13F filing for Q4 2021, filed 14 Feb 2022.